Transcription of ACOG PRACTICE BULLETIN
{{id}} {{{paragraph}}}
CLINICAL MANAGEMENT GUIDELINES FOR OBSTETRICIAN GYNECOLOGISTSNUMBER 107, AUGUST 2009 Replaces PRACTICE BULLETIN Number 10, November 1999; Committee Opinion Number 228, November1999; Committee Opinion Number 248, December 2000; Committee Opinion Number 283, May 2003 This PRACTICE BULLETIN was devel-oped by the ACOG Committee onPractice Bulletins Obstetrics withthe assistance of Mildred Ramirez,MD, and Susan Ramin, MD. Theinformation is designed to aid prac-titioners in making decisions aboutappropriate obstetric and gyneco-logic care. These guidelines shouldnot be construed as dictating anexclusive course of treatment orprocedure. Variations in practicemay be warranted based on theneeds of the individual patient,resources, and limitations unique tothe institution or type of of LaborMore than 22% of all gravid women undergo induction of labor in the UnitedStates, and the overall rate of induction of labor in the United States has morethan doubled since 1990 to 225 per 1,000 live births in 2006 (1).
reduced risk of uterine tachysystole with or without fetal heart rate (FHR) changes (18, 21). Misoprostol, a synthetic PGE 1 analogue, can be administered intravaginally, orally, or sublingually and is used for both cervical ripening and induction of labor. It currently is available in a 100-mcg (unscored) or a 200-
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}